Three Washington, D.C., healthcare policy experts and the former chief of staff of HHS dive into the healthcare politics and policies of the new administration: RFK Jr.’s confirmation hearings; the ...
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...
Solid Biosciences reported recent positive data in developing their gene therapy candidate SGT-003. The phase 1/2 INSPIRE ...
Medicaid is a needs-based program, but the misconception that it is a program solely for poor people has made it a target for ...
Simlandi and adalimumab-adaz have been with on formulary, along with Humira, beginning Jan. 1, 2025, Arpit Patel, Pharm.D., ...
Blue Cross Blue Shield of Michigan said it is evaluating any potential updates to the coverage process for Darzalex Faspro ...
At what was supposed to be a hearing to discuss PBM reform, some in Congress veered off into discussions about Medicaid and ...
But major cuts to federal for Medicaid are a likely outcome of the $1.5-$2 trillion in spending cuts over the next 10 years ...
Unlike some other spending cuts, Medicaid cuts will have direct impact on people who voted for Republicans in November 2024, ...
This once-daily topical treatment is the latest phosphodiesterase-4 (PDE4) inhibitor designed for mild to moderate atopic ...
The FDA has accepted the biologics licensing application (BLA) resubmission for odronextamab, a potential treatment for ...
The new lower prices apply to some doses of Zepbound provided in vials but not the autoinjector pens.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果